title: Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.
abstract: Churg-Strauss vasculitis (CSV) is a systemic vasculitis usually treated with steroids and cytotoxic drugs. Herein, we describe the beneficial effect of intravenous immune globulin (IVIG) in a 50-year-old man with CSV. The IVIG therapy brought a marked clinical improvement, with impressive decline in the titers of antineutrophil cytoplasmic autoantibody.
authors.affiliation: Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Levy
authors.forename: J
authors.initials: J
authors.lastname: George
authors.forename: F
authors.initials: F
authors.lastname: Fabbrizzi
authors.forename: P
authors.initials: P
authors.lastname: Rotman
authors.forename: Y
authors.initials: Y
authors.lastname: Paz
authors.forename: Y
authors.initials: Y
authors.lastname: Shoenfeld
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000187:drug effects; D015267:Churg-Strauss Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D016756:Immunoglobulins, Intravenous